Franklin Genomic Advancem... (HELX)
Franklin Genomic Advancements ETF Max Pain By Strike
HELX trades at $29.63, 23.5% above the near-term max pain of $24 expiring Sep 19, 2025 (31 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($21-$500), signaling increased put positioning or downside protection. Key magnetic zone at 24 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Franklin Genomic Advancements ETF Max Pain By Expiry
Max pain for HELX shows a downward trend from 500 to 21, indicating bearish sentiment or hedging activity. The 403% spread signals divergent expectations across timeframes. Most levels below 29.63 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 24 | -5.63 (-19.00%) |
| Oct 17, 2025 | 26 | -3.63 (-12.25%) |
| Nov 21, 2025 | 21 | -8.63 (-29.13%) |
| Jan 16, 2026 | 500 | 470.37 (1587.48%) |
| Feb 20, 2026 | 24 | -5.63 (-19.00%) |